Loading clinical trials...
Loading clinical trials...
A Prospective, Multicenter, Observational Study of LUMRYZ Used in Clinical Practice for the Treatment of Narcolepsy
This is an observational study of LUMRYZ prescribed in clinical practice. Patients are asked if they would be willing to complete questionnaires over a 4-month period after starting LUMRYZ. The questionnaires ask about narcolepsy symptoms, experience with LUMRYZ, and quality of life.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Jeremy D McConnell, MD PA
Bradenton, Florida, United States
Comprehensive Sleep Center
East Lansing, Michigan, United States
Patient First MD
Middletown, New Jersey, United States
Ghaly Sleep Management Services
East Syracuse, New York, United States
University Hospitals Cleveland Medical Center
Cleveland, Ohio, United States
Ohio Sleep Medicine Institute
Dublin, Ohio, United States
Abington Neurological Associates
Abington, Pennsylvania, United States
Pulmonology Associates, Inc.
Wynnewood, Pennsylvania, United States
Respiratory Specialists
Wyomissing, Pennsylvania, United States
Bogan Sleep Consultants
Columbia, South Carolina, United States
Start Date
July 18, 2024
Primary Completion Date
October 28, 2025
Completion Date
October 28, 2025
Last Updated
February 13, 2026
71
ACTUAL participants
LUMRYZ
DRUG
Lead Sponsor
Avadel
NCT07363720
NCT06952699
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06809803